Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial
- Resource Type
- Article
- Source
- The Lancet HIV; May 2018, Vol. 5 Issue: 5 pe211-e220, 10p
- Subject
- Language
- ISSN
- 24054704; 23523018